Lv1
30 积分 2024-01-29 加入
Pathological complete response in RET-positive non-small cell lung cancer: a case report of pralsetinib-based “sandwich” therapy
14小时前
求助中
Recurrence of Non–Small Cell Lung Cancer With Visceral Pleural Invasion
12天前
已完结
MARIPOSA: phase 3 study of first-line amivantamab + lazertinib versus osimertinib in EGFR-mutant non-small-cell lung cancer
15天前
已完结
Nivolumab plus ipilimumab with chemotherapy for non–small cell lung cancer with untreated brain metastases: a multicenter single-arm phase 2 trial (NIke, LOGiK 2004)
1个月前
已完结
Predicting survival in small cell lung cancer patients undergoing various treatments: a machine learning approach
1个月前
已完结
Small cell lung cancer
1个月前
已完结
Outcomes With Pembrolizumab Plus Platinum-Based Chemotherapy for Patients With NSCLC and Stable Brain Metastases: Pooled Analysis of KEYNOTE-021, -189, and -407
1个月前
已完结
Pembrolizumab for management of patients with NSCLC and brain metastases: long-term results and biomarker analysis from a non-randomised, open-label, phase 2 trial
1个月前
已完结
Cemiplimab monotherapy as first‐line treatment of patients with brain metastases from advanced non–small cell lung cancer with programmed cell death‐ligand 1 ≥50%
1个月前
已完结
Phase II Trial of Atezolizumab Combined With Carboplatin and Pemetrexed for Patients With Advanced Nonsquamous Non–Small-Cell Lung Cancer With Untreated Brain Metastases (Atezo-Brain, GECP17/05)
1个月前
已完结
皖公网安备34019202002308
